Skip to content
Clinical Trials – home
CroatiaBack to Croatia

Clinical trials in Solin – page 6

66 clinical trials in Solin, Croatia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Solin at a glance
66
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

66 trials in Solin

Open in trial search

Bladder cancer

Not recruiting

Study Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer

Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Colitis ulcerative

Not recruiting

Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis

Investigational
Countries:CroatiaCroatia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

IgA nephropathy

Not recruiting

Study on Sibeprenlimab for Patients with IgA Nephropathy

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Sibeprenlimab
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Dermatitis atopic

Not recruiting

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Investigational
Countries:CroatiaCroatia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Renal cell carcinoma

Not recruiting

Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Solin

What the registry says about research in the country

01 Nutritional and Metabolic Diseases – Weight Management Trial

The study examines whether NNC0487-0111 can produce greater reductions in body weight compared with placebo in adults living with overweight or obesity and type 2 diabetes.

  • Superiority test against placebo
  • Focus on weight change outcomes
  • Inclusion of participants with both conditions
  • Potential improvement in metabolic health

The trial is being conducted in Solin, Croatia, at the city's primary research site.

02 Nutritional and Metabolic Diseases – Glycaemic Control Trial

This trial compares the effectiveness of zenagamtide to semaglutide for lowering glycated haemoglobin (HbA1c) and reducing body weight in patients with type 2 diabetes inadequately controlled on stable doses of metformin and/or SGLT2i.

  • Non‑inferiority design versus an established therapy
  • Evaluation of blood‑sugar control
  • Assessment of weight outcomes
  • Targeting individuals on combination medication

The study involves a single investigator at the Solin clinical research centre.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.